Trial intelligence / Profile preview

Flurbiprofen timing for prevention of intraoperative nausea and vomiting during cesarean delivery

jRCTs031260480Recruiting

Start
Sep 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of flurbiprofen axetil in intraoperative nausea and vomiting (IONV) (2 arms). Primary endpoint: Proportion of patients with clinically significant intraoperative nausea and vomiting. Started Sep 2026; status: recruiting.

02

Drugs

flurbiprofen axetil
03

Conditions

intraoperative nausea and vomiting (IONV)

Beyond the preview

Go deeper on jRCTs031260480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031260480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call